EDSA Edesa Biotech, Inc. Common Shares · XNAS
2.02 -18.9% as of Nov 10, 13:55 ET
fans
What's happening Live detector signal Generated 00:51 ET
Share structure
Free float
7.2M
2026-08-25
Shares out
9.6M
latest detail
Market cap
$19.5M
at ref price
Short interest
2.2%
2026-10-30
Float rotation
0.23×
latest snapshot
20d dollar vol
$13.1M
baseline
Supply intelligence
Gap quality
clean gap · 72
live supply-pressure model
Supply factor
negative gap pressure
detector reason
Supply factor
low float
detector reason
Supply factor
meaningful float rotation
detector reason
Supply factor
nano-cap supply profile
detector reason

This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.

Filings and news
2026-11-10 13:55 ETSignalEdesa Biotech, Inc. Common Shares is down 18.9%, at 2.02, on $3.3M traded, 0.23× float rotation. Score 72. Primary driver: 22.6% float rotation. Supply intelligence: clean gap · 72.
2026-11-098-KItem 1.01 — Entry into a material definitive agreement; Item 1.02 — Termination of a material definitive agreement +1 more SEC
2026-10-238-KItem 5.02 — Director or officer departure/election/appointment SEC
2026-10-158-KItem 8.01 — Other events SEC
2026-08-208-KItem 1.01 — Entry into a material definitive agreement; Item 8.01 — Other events +1 more SEC
2026-08-20424B5Potential financing or dilution-related filing. SEC
2026-08-19424B5Potential financing or dilution-related filing. SEC
2026-06-03 13:00 ETFDA / ClinicalAcute Respiratory Distress Syndrome Market to Grow Steadily at a 3.8% CAGR Through 2036, Supported by Emerging ARDS Therapies | DelveInsight News
2025-08-14 13:00 ETFDA / ClinicalVitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight News
2025-02-13 09:00 ETMna StrategicInformation Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital News
2024-09-13 19:38 ETMna StrategicPardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc. News
Latest detector signalscore 72
score 72